CP-690550A is a novel JAK3 inhibitor, an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders. References: Yamaoka K. Relation between disease modifying anti-rheumatic drugs and herpes zoster in rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):181-9. doi: 10.2177/jsci.39.181. PubMed PMID: 27320933.

纯度：≥98%

CAS：1243290-37-0